HOME › DRUGS › PLERIXAFOR
ACTIVE SUBSTANCE / INN

PLERIXAFOR

Brand name(s): PLERIXAFOR, MOZOBIL, Mozobil, Plerixafor Accord
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA213672
Multiple Myeloma;Hematopoietic Stem Cell Transplantation
ACTIVE SUBSTANCE
Plerixafor
REGULATORS
FDA · EMA
SPONSORS / MAH
EUGIA PHARMA, GENZYME, ZYDUS PHARMS
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PLERIXAFORANDA213672EUGIA PHARMAPrescription
MOZOBILNDA022311GENZYMEPrescription
PLERIXAFORANDA208980ZYDUS PHARMSDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MozobilSanofi B.V.Authorised30/07/2009Multiple Myeloma;Hematopoietic Stem Cell Transplantation;Lymphoma
Plerixafor AccordAccord Healthcare S.L.U.Authorised16/12/2022Multiple Myeloma;Hematopoietic Stem Cell Transplantation

FULL INTELLIGENCE ON PLERIXAFOR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →